Allogene Therapeutics (ALLO) Asset Utilization Ratio (2021 - 2024)
Allogene Therapeutics (ALLO) has disclosed Asset Utilization Ratio for 4 consecutive years, with 0.0 as the latest value for Q4 2024.
- Quarterly Asset Utilization Ratio fell 72.4% to 0.0 in Q4 2024 from the year-ago period, while the trailing twelve-month figure was 0.0 through Dec 2024, down 72.4% year-over-year, with the annual reading at 0.0 for FY2024, 71.54% down from the prior year.
- Asset Utilization Ratio hit 0.0 in Q4 2024 for Allogene Therapeutics, down from 0.0 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 0.11 in Q4 2021 to a low of 0.0 in Q4 2024.
- Historically, Asset Utilization Ratio has averaged 0.03 across 4 years, with a median of 0.0 in 2023.
- Biggest five-year swings in Asset Utilization Ratio: soared 135.45% in 2022 and later crashed 99.84% in 2023.
- Year by year, Asset Utilization Ratio stood at 0.11 in 2021, then crashed by 99.83% to 0.0 in 2022, then fell by 22.95% to 0.0 in 2023, then crashed by 72.4% to 0.0 in 2024.
- Business Quant data shows Asset Utilization Ratio for ALLO at 0.0 in Q4 2024, 0.0 in Q3 2024, and 0.0 in Q2 2024.